Market Research Logo

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Microbiome Therapeutics Market 2018 Forecast to 2023

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Microbiome Therapeutics Market 2018 Forecast to 2023

The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

Scope of the Report:
This report focuses on the Microbiome Therapeutics in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Market Segment by Applications, can be divided into
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others

There are 15 Chapters to deeply display the global Microbiome Therapeutics market.

Chapter 1, to describe Microbiome Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Microbiome Therapeutics, with sales, revenue, and price of Microbiome Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Microbiome Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Microbiome Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Microbiome Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 C. difficile Infection (CDI)
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Orphan Drug
1.3.4 Immuno-oncology
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.2 Microbiome Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.2 Microbiome Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Interxon
2.4.1 Business Overview
2.4.2 Microbiome Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 PureTech
2.5.1 Business Overview
2.5.2 Microbiome Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Synlogic
2.6.1 Business Overview
2.6.2 Microbiome Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.2 Microbiome Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 4D Pharma
2.8.1 Business Overview
2.8.2 Microbiome Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Second Genome
2.9.1 Business Overview
2.9.2 Microbiome Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AOBiome
2.10.1 Business Overview
2.10.2 Microbiome Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 Microbiome Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Microbiome Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 Microbiome Therapeutics Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Microbiome Therapeutics Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Microbiome Therapeutics Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Microbiome Therapeutics Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 Microbiome Therapeutics Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Microbiome Therapeutics Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Microbiome Therapeutics Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Osel
2.20.1 Business Overview
2.20.2 Microbiome Therapeutics Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Metabogen
2.21.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Microbiome Therapeutics Market Competition, by Manufacturer
3.1 Global Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Microbiome Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Microbiome Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 Microbiome Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Microbiome Therapeutics Market Analysis by Regions
4.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Microbiome Therapeutics Sales by Regions (2013-2018)
4.1.2 Global Microbiome Therapeutics Revenue by Regions (2013-2018)
4.2 North America Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 North America Microbiome Therapeutics by Countries, Type, Application and Manufacturers
5.1 North America Microbiome Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Microbiome Therapeutics Sales by Countries (2013-2018)
5.1.2 North America Microbiome Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Microbiome Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 Europe Microbiome Therapeutics by Countries, Type, Application and Manufacturers
6.1 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Microbiome Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe Microbiome Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Microbiome Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Microbiome Therapeutics by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Microbiome Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Microbiome Therapeutics Revenue by Countries (2013-2018)
7.1.3 China Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Microbiome Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 South America Microbiome Therapeutics by Countries, Type, Application and Manufacturers
8.1 South America Microbiome Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Microbiome Therapeutics Sales by Countries (2013-2018)
8.1.2 South America Microbiome Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Microbiome Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Microbiome Therapeutics by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Microbiome Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Microbiome Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Microbiome Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Microbiome Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Microbiome Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Microbiome Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Microbiome Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Microbiome Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Microbiome Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 Global Microbiome Therapeutics Market Segment by Type
10.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
11 Global Microbiome Therapeutics Market Segment by Application
11.1 Global Microbiome Therapeutics Sales Market Share by Application (2013-2018)
11.2 C. difficile Infection (CDI) Sales Growth (2013-2018)
11.3 Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
11.4 Orphan Drug Sales Growth (2013-2018)
11.5 Immuno-oncology Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Microbiome Therapeutics Market Forecast (2018-2023)
12.1 Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Microbiome Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Microbiome Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Microbiome Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Microbiome Therapeutics Market Forecast (2018-2023)
12.2.4 South America Microbiome Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Microbiome Therapeutics Market Forecast (2018-2023)
12.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Microbiome Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Microbiome Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure Global Microbiome Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Microbiome Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Microbiome Therapeutics by Types in 2017
Figure Microbiome Therapeutics Sales Market Share by Applications in 2017
Figure C. difficile Infection (CDI) Picture
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure United States Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Microbiome Therapeutics Type and Applications
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table Assembly Biosciences Microbiome Therapeutics Type and Applications
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics Microbiome Therapeutics Type and Applications
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Interxon Basic Information, Manufacturing Base and Competitors
Table Interxon Microbiome Therapeutics Type and Applications
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PureTech Basic Information, Manufacturing Base and Competitors
Table PureTech Microbiome Therapeutics Type and Applications
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synlogic Basic Information, Manufacturing Base and Competitors
Table Synlogic Microbiome Therapeutics Type and Applications
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table Enterome BioScience Microbiome Therapeutics Type and Applications
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table 4D Pharma Basic Information, Manufacturing Base and Competitors
Table 4D Pharma Microbiome Therapeutics Type and Applications
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Second Genome Basic Information, Manufacturing Base and Competitors
Table Second Genome Microbiome Therapeutics Type and Applications
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AOBiome Basic Information, Manufacturing Base and Competitors
Table AOBiome Microbiome Therapeutics Type and Applications
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C3 Jian Basic Information, Manufacturing Base and Competitors
Table C3 Jian Microbiome Therapeutics Type and Applications
Table C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Microbiome Therapeutics Type and Applications
Table Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Type and Applications
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabiomics Basic Information, Manufacturing Base and Competitors
Table Metabiomics Microbiome Therapeutics Type and Applications
Table Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ritter Pharmaceuticals Microbiome Therapeutics Type and Applications
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symberix Basic Information, Manufacturing Base and Competitors
Table Symberix Microbiome Therapeutics Type and Applications
Table Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OpenBiome Basic Information, Manufacturing Base and Competitors
Table OpenBiome Microbiome Therapeutics Type and Applications
Table OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Azitra Basic Information, Manufacturing Base and Competitors
Table Azitra Microbiome Therapeutics Type and Applications
Table Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symbiotix Biotherapies Basic Information, Manufacturing Base and Competitors
Table Symbiotix Biotherapies Microbiome Therapeutics Type and Applications
Table Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Osel Basic Information, Manufacturing Base and Competitors
Table Osel Microbiome Therapeutics Type and Applications
Table Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabogen Basic Information, Manufacturing Base and Competitors
Table Metabogen Microbiome Therapeutics Type and Applications
Table Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Global Microbiome Therapeutics Price by Manufacturer (2016-2017)
Figure Top 3 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Microbiome Therapeutics Sales and Growth Rate (2013-2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report